DMAAR vs O · $1.8M cap vs P/E 50, rev $3.10B
Drugs Made In America Acquisition Corp. Rights (DMAAR) versus Realty Income Corporation (O) — a side-by-side from cached financials, not a winner call.
Drugs Made In America Acquisition Corp. Rights (DMAAR) common stock listed on US.
Realty Income Corporation (O) is a reit - retail company listed on NYSE.
DMAAR does not have a complete income-statement cache yet.
Latest reported O revenue for 2026-06-30 was $3.10B. Net income was $691.4M. Revenue was up 99.9% from 2026-03-31 to 2026-06-30. O currently screens at market cap $56.48B and trailing P/E 49.6.
DMAAR currently screens at market cap $1.8M. O currently screens at market cap $56.48B and trailing P/E 49.6.
Not investment advice. Open the DMAAR and O stock pages for the full models.
Not investment advice.